I-131-Omburtamab
131I-Omburtamab (131I-Burtomab, 131I-8H9) is a monoclonal murine antibody, labeled [...]
I-131-Naxitamab
131I-Naxitamab (131I-3F8) is a murine antibody targeting GD2 (disialoganglioside), labeled [...]
I-131-CAM-H2
131I-CAM-H2 (131I-SGMIB anti-HER2-VHH1; 131I-SGMIB) is a targeted radionuclide therapeutic drug [...]
Sn-117m-HTC (Synovetin)
117mSn-HTC (117mSn-Tin Colloid, Synovetin OA) is developed and was brought [...]
Th-227-Anetumab corixetan
227Th-Anetumab corixetan (227Th-BAY2287411) is a mesothelin targeted thorium conjugate (MSLN-TTC) [...]
Ra-224-RadSpherin
224Ra-RadSpherin is a suspension of Radium-224 in degradable calcium carbonate [...]
Sn-117m-DTPA
117mSn-DTPA was studied in the years 1990s by Brookhaven National [...]
Ho-166- Microspheres
166Ho-microspheres is a product developed at the University Medical Center [...]
First patients dosed in clinical trial of novel lung and ovarian cancer theranostic
Telix Pharmaceuticals Limited announced that the first two patients have [...]
Sm-153-Oxabiphor (ETMP)
153Sm-Oxabiphor (153Sm-ETMP) is a therapeutic agent with a profile similar [...]